Professor
Seoul Natl Univ Coll of Medicine & Hosp, Republic of Korea
Dr. Howard Lee is the Founder and Director of the Center for Convergence Approaches in Drug Development (CCADD), Seoul National University. Dr. Lee serves as a Professor at the Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Seoul National University College of Medicine and Hospital, affiliated with the Department of Clinical Pharmacology and Therapeutics.
Dr. Lee is board-certified in Family Medicine and Clinical Pharmacology and holds a PhD in Epidemiology. Dr. Lee completed a fellowship in Clinical Pharmacology at the Center for Drug Development Science (CDDS), Department of Pharmacology, Georgetown University School of Medicine in Washington DC, USA, where he subsequently served as an Assistant Professor of Medicine and eventually became Director after CDDS has joined the University of California San Francisco in association with the School of Pharmacy. Dr. Lee also had served as faculty in two other US-based universities including the University of California San Francisco and the University of Pittsburgh.
Since returning to Korea in late 2012, Dr. Lee has served as the principal investigator in >25 clinical pharmacology studies including eight first-in-human studies. Furthermore, Dr. Lee has spearhead the introduction of the Accelerator Mass Spectrometry (AMS)-enabled exploratory microtracing study in early clinical drug development studies to the Korean biopharmaceutical R&D sector. Dr. Lee has received three government grants in microtracing. The most recent one (2017) was to expand the technology to the development of a new biologic first time, which has not been tried by anyone in the world.